IL152401A0 - New polycyclic indanylimidazoles with alpha2 adrenergic activity - Google Patents

New polycyclic indanylimidazoles with alpha2 adrenergic activity

Info

Publication number: IL152401A0
Authority: IL; Israel
Prior art keywords: indanylimidazoles; alpha2 adrenergic; adrenergic activity; new polycyclic; alpha2
Prior art date: 2000-05-08

Application number

IL15240101A

Other languages

English (en)

Original Assignee

Orion Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-08

Filing date

2001-05-07

Publication date

2003-05-29

2001-05-07 Application filed by Orion Corp filed Critical Orion Corp

2003-05-29 Publication of IL152401A0 publication Critical patent/IL152401A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL15240101A 2000-05-08 2001-05-07 New polycyclic indanylimidazoles with alpha2 adrenergic activity IL152401A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FI20001065		2000-05-08
PCT/FI2001/000434 WO2001085698A1 (en)	2000-05-08	2001-05-07	New polycyclic indanylimidazoles with alpha2 adrenergic activity

Publications (1)

Publication Number	Publication Date
IL152401A0 true IL152401A0 (en)	2003-05-29

Family

ID=8558343

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15240101A IL152401A0 (en)	2000-05-08	2001-05-07	New polycyclic indanylimidazoles with alpha2 adrenergic activity

Country Status (16)

Country	Link
US (1)	US6362211B2 (de)
EP (1)	EP1280779B1 (de)
JP (1)	JP2003532712A (de)
AT (1)	ATE302757T1 (de)
AU (2)	AU5846901A (de)
CA (1)	CA2408290A1 (de)
CZ (1)	CZ20023674A3 (de)
DE (1)	DE60112917T2 (de)
ES (1)	ES2247107T3 (de)
IL (1)	IL152401A0 (de)
NO (1)	NO20025323D0 (de)
NZ (1)	NZ522274A (de)
PE (1)	PE20011321A1 (de)
PT (1)	PT1280779E (de)
RU (1)	RU2002132883A (de)
WO (1)	WO2001085698A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2835834B1 (fr) *	2002-02-14	2004-04-02	Pf Medicament	Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments
FR2839719B1 (fr) *	2002-05-16	2004-08-06	Pf Medicament	Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
US8188126B2 (en)	2002-05-16	2012-05-29	Pierre Fabre Medicament	Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
WO2010017120A1 (en) *	2008-08-04	2010-02-11	Schering Corporation	Cyclopropylchromene derivatives as modulators of the alpha-2c receptor
US10826751B2 (en) *	2009-12-28	2020-11-03	Telefonaktiebolaget Lm Ericsson (Publ)	Management of functional interconnections between application modules on resource nodes in a social web
US12241892B2 (en)	2017-06-26	2025-03-04	Bio-Rad Europe Gmbh	In situ serial dilution method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2167408B (en) *	1984-11-23	1988-05-25	Farmos Oy	Substituted imidazole derivatives and their preparation and use
FI81092C (fi)	1986-05-15	1990-09-10	Farmos Oy	Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
GB2225782A (en)	1988-12-09	1990-06-13	Farmos Group Limited	Imidazole derivatives useful for treatment of diabetes
GB9425211D0 (en)	1994-12-14	1995-02-15	Ucb Sa	Substituted 1H-imidazoles
GB9520150D0 (en) *	1995-10-03	1995-12-06	Orion Yhtymae Oy	New imidazole derivatives

2001
- 2001-05-07 NZ NZ522274A patent/NZ522274A/en unknown
- 2001-05-07 RU RU2002132883/04A patent/RU2002132883A/ru not_active Application Discontinuation
- 2001-05-07 CA CA002408290A patent/CA2408290A1/en not_active Abandoned
- 2001-05-07 AU AU5846901A patent/AU5846901A/xx active Pending
- 2001-05-07 WO PCT/FI2001/000434 patent/WO2001085698A1/en not_active Ceased
- 2001-05-07 PT PT01931766T patent/PT1280779E/pt unknown
- 2001-05-07 AU AU2001258469A patent/AU2001258469B2/en not_active Ceased
- 2001-05-07 AT AT01931766T patent/ATE302757T1/de not_active IP Right Cessation
- 2001-05-07 EP EP01931766A patent/EP1280779B1/de not_active Expired - Lifetime
- 2001-05-07 JP JP2001582299A patent/JP2003532712A/ja active Pending
- 2001-05-07 CZ CZ20023674A patent/CZ20023674A3/cs unknown
- 2001-05-07 IL IL15240101A patent/IL152401A0/xx unknown
- 2001-05-07 DE DE60112917T patent/DE60112917T2/de not_active Expired - Fee Related
- 2001-05-07 US US09/849,540 patent/US6362211B2/en not_active Expired - Fee Related
- 2001-05-07 ES ES01931766T patent/ES2247107T3/es not_active Expired - Lifetime
- 2001-05-07 PE PE2001000409A patent/PE20011321A1/es not_active Application Discontinuation
2002
- 2002-11-06 NO NO20025323A patent/NO20025323D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE60112917D1 (de)	2005-09-29
AU5846901A (en)	2001-11-20
EP1280779B1 (de)	2005-08-24
JP2003532712A (ja)	2003-11-05
NZ522274A (en)	2004-11-26
PE20011321A1 (es)	2002-01-03
EP1280779A1 (de)	2003-02-05
NO20025323L (no)	2002-11-06
CA2408290A1 (en)	2001-11-15
PT1280779E (pt)	2005-11-30
WO2001085698A1 (en)	2001-11-15
CZ20023674A3 (cs)	2003-09-17
DE60112917T2 (de)	2006-06-08
NO20025323D0 (no)	2002-11-06
AU2001258469B2 (en)	2005-04-14
ATE302757T1 (de)	2005-09-15
US6362211B2 (en)	2002-03-26
US20020013356A1 (en)	2002-01-31
ES2247107T3 (es)	2006-03-01
RU2002132883A (ru)	2004-04-20

Publication	Publication Date	Title
DE60015927D1 (en)	2004-12-23	Phenylharnstoff und phenylthioharnstoffderivate
ES2187473T3 (es)	2003-06-16	Triarylimidazoles.
BG104670A (en)	2001-05-31	4-(2-keto-1-benzimidazolinyl)piperidinne compounds as orl1-receptor agonists
PL361355A1 (en)	2004-10-04	Phenylglycine derivatives
EP0669324A4 (de)	1996-04-03	Chinazolin derivate.
PT1109812E (pt)	2005-09-30	Pirrolobenzodiazepinas
NZ514662A (en)	2004-01-30	Amine derivatives
GB9929552D0 (en)	2000-02-09	Compounds
SE0004245D0 (sv)	2000-11-20	Novel compounds and their use
HRP20041026A2 (en)	2005-06-30	Polycyclic compounds as potent alpha2-adrenoceptor antagonists
AU2267495A (en)	1995-11-16	Benzamide derivatives as vasopressin antagonists
PL341239A1 (en)	2001-03-26	Dihydrobenzofuranes
WO1999009965A3 (en)	1999-05-20	Anti-inflammatory agent
IL153352A0 (en)	2003-07-06	Coumarin derivatives with comt inhibiting activity
TW340109B (en)	1998-09-11	Amide derivatives and their therapeutic use
IL152401A0 (en)	2003-05-29	New polycyclic indanylimidazoles with alpha2 adrenergic activity
HRP20010885B1 (en)	2010-07-31	Ethanesulfonyl-piperidine derivatives
MX9709466A (es)	1998-02-28	Medicamento para inhibir el melanoma.
DE69837999D1 (en)	2007-08-09	Herbizide furanyl- und thienyloxyazine
AP2002002595A0 (en)	2002-09-30	Heterocyclic amide derivatives.
DE69615657D1 (de)	2001-11-08	Antifungal fusacandine
EP0919554A4 (de)	2002-05-29	Durch imidazol substituierte chinoxalindion-derivate
BG105252A (en)	2001-12-29	Isoquinolines as urokinase inhibitors
SI0937075T1 (en)	2004-06-30	New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
AU758194C (en)	2004-04-08	Novel benzimidazoles and benzoxazoles